MedTrace Logo

TAPB vs QLBII for Kidney Transplantation Procedure

NCT02783586 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2018-05-22

No results posted yet for this study

Summary

The main advantage of Quadratus Lumborum Block (QLB) compared to Transversus Abdominalis Plane Block (TAPB) is the impact on visceral pain due to the spread of the local anaesthetic agent to the paravertebral space. It may produce extensive analgesia and better pain control.

Previews studies shoved the effectiveness of TAPB in kidney transplantation procedure (KTX) by reducing opioids requirements during and after the operation. QLB was not evaluating in KTX procedure yet, but it reduced postoperative morphine requirement after cesarean section under spinal anaesthesia.

The aim of this prospective, randomised controlled, multicenter, clinical study is to compare the perioperative analgesic efficacy of QLB and TAPB in patients who had KTX under balanced (general and regional) anaesthesia.

Conditions

  • Postoperative Pain

Interventions

PROCEDURE

Quadratus Lumborum Block type II

Local anaesthetic injection on the posterior border of the quadratus lumborum muscle

PROCEDURE

Transversus Abdominalis Plane Block

Local anaesthetic injection between internal oblique and transversus abdominis muscle

DRUG

Bupivacaine

20 ml of bupivacaine with adrenaline

DEVICE

Ultraplex

A non-stimulating echogenic single-shot needle designed for regional analgesia under ultrasound guidance.

Sponsors & Collaborators

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Marcin Kolacz, MD,PhD · Medical University of Warsaw

  • Marcin Mieszkowski, MD · Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, Poland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-08
Primary Completion
2017-05-29
Completion
2017-05-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02783586 on ClinicalTrials.gov